Powder: -20°C for 3 years | In solvent: -80°C for 1 year
TAK285-IODO, similar to TAK285 in which the trifluoro group is replaced by iodo, is a novel dual erbB protein kinase inhibitor that specifically targets human epidermal growth factor receptor (EGFR) and HER2.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
100 mg | Inquiry | Inquiry | |
500 mg | Inquiry | Inquiry |
Description | TAK285-IODO, similar to TAK285 in which the trifluoro group is replaced by iodo, is a novel dual erbB protein kinase inhibitor that specifically targets human epidermal growth factor receptor (EGFR) and HER2. |
Synonyms | TAK-285-Iodo, TAK 285-Iodo, TAK285 derative |
Molecular Weight | 605.86 |
Formula | C25H25ClIN5O3 |
CAS No. | T34775 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
TAK285-Iodo T34775 TAK285Iodo TAK285 Iodo TAK-285-Iodo TAK 285-Iodo TAK285 derative inhibitor inhibit